Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
RANKL is a cytokine produced as a membrane-bound and a secreted protein. Here, using mice lacking soluble RANKL, the authors show that the secreted protein is important for osteoclast function, but not for mammary gland and lymphocyte development.
Saved in:
Main Authors: | Jinhu Xiong, Keisha Cawley, Marilina Piemontese, Yuko Fujiwara, Haibo Zhao, Joseph J. Goellner, Charles A. O’Brien |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/f3fdb2bc80d5499aa847b891e2ea7b50 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity
by: Huang JM, et al.
Published: (2021) -
Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
by: Marcelline K Hanson, et al.
Published: (2021) -
Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.
by: Yoshiki Nakashima, et al.
Published: (2013) -
Anti-Osteoporotic Effects of <i>n-trans</i>-Hibiscusamide and Its Derivative Alleviate Ovariectomy-Induced Bone Loss in Mice by Regulating RANKL-Induced Signaling
by: Hyung Jin Lim, et al.
Published: (2021) -
KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
by: Shu-Fen Liou, et al.
Published: (2013)